Navigation Links
HGS announces positive Phase 2 LymphoStat-B at ACR meeting
Date:11/9/2007

ROCKVILLE, Maryland November 9, 2007 Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced the presentation of Phase 2 clinical results demonstrating that LymphoStat-B (belimumab) achieved a sustained improvement in disease activity across multiple clinical measures, decreased the frequency of disease flares over time, and was well tolerated through 2.5 years on treatment in combination with standard of care in patients with active systemic lupus erythematosus (SLE). The results will be the subject of an oral presentation today in Boston at the Annual Scientific Meeting of the American College of Rheumatology (ACR).

SLE is a chronic disease, and patients need new therapies that provide durable efficacy with a favorable safety profile, said Michelle A. Petri, M.D., M.P.H., Professor, Division of Rheumatology, Department of Medicine, Johns Hopkins University. The Phase 2 results presented at ACR showed that the significant clinical benefit observed for LymphoStat-B in serologically active SLE patients at 52 weeks appears to be sustained through 2.5 years. We look forward to further evaluation of LymphoStat-B in larger Phase 3 studies, which are ongoing.

A separate poster presentation of the safety profile of LymphoStat-B showed that LymphoStat-B was well tolerated in combination with SLE standard-of-care therapy during long-term exposure, with incidence rates of adverse events, serious adverse events, malignancies, infections and laboratory abnormalities remaining comparable to placebo or decreasing through 2.5 years of treatment (Merrill et al).

The results through 2.5 years confirm and extend the results reported at Weeks 52 and 76, said David C. Stump, M.D., Executive Vice President, Research and Development, HGS. At Week 52 in LymphoStat-B patients with active SLE, we saw significant reductions in SLE disease activity versus placebo as measured by the SELENA SLEDAI and BILAG indices, the Physicians Global Assessment,
'/>"/>

Contact: Jerry Parrot
Jerry_Parrott@hgsi.com
301-315-2777
Edelman Public Relations
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
2. LaserCard Corporation Announces Expansion of Middle East Project
3. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
4. Balzan Foundation announces 2007 winners
5. The American Society of Plant Biologists announces 2007 awards
6. ASPB announces Summer Undergraduate Research Fellowship 2007 recipients
7. NIST announces 56 new awards for innovative technology research and development
8. Titanium Group Announces Contract With Haitong Securities
9. Measurement Specialties, Inc. Announces Impact of German Business Tax Reform 2008 Resulting in Lower Combined German Tax Rate - Impacts 2Q08 Reported Financial Results
10. FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change
11. Positive results for airway bypass
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2015)... 21, 2015 Today, ZTE announced its Android ... well as expected revenues in 2015 that relate to sales of ... guidance of approximately 2,200 MSEK for 2015. Jörgen Lantto, ... smartphone manufacturer in China and we are ... 5 for Axon , its ...
(Date:7/20/2015)... DENVER , July 20, 2015  Acuity ... Mobility Report: The Convergence of Commerce and Privacy" ... billion mobile biometric apps will be downloaded to ... users. The mobile biometrics market is projected to ... app revenue during the seven-year forecast period.    ...
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 30, 2015 after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... can build its way to a more energy efficient future ... by improving the rules regulating these structures, according to ... Laboratory. PNNL scientists at the Joint Global Change Research ... Park, Md., have created a unique model that projects how ...
... Like little factories, cells metabolize raw materials and ... of this ability, using microorganisms to produce pharmaceuticals ... scale and create new types of chemicals, biotechnologists ... certain genes in the cell. But such metabolic ...
... have identified how a single gene in honey bees separates ... from Michigan State University and Wayne State University unraveled the ... issue of Biology Letters . The gene, which is ... in the evolution of bees, ability to carry pollen. ...
Cached Biology News:Modeling buildings by the millions: Building codes in China tested for energy savings 2Modeling buildings by the millions: Building codes in China tested for energy savings 3Modeling buildings by the millions: Building codes in China tested for energy savings 4A digital test for toxic genes 2A digital test for toxic genes 3Single gene separates queen from workers 2
(Date:8/5/2015)... WASHINGTON , Aug. 5, 2015 ... Energy and Commerce Committee members Reps. Joe Barton ... well as a delegation of 33 House members, for ... Slavitt , acting administrator for the Centers for Medicare ... biosimilar reimbursement in the CMS,s 2016 Medicare Physician Fee ...
(Date:8/5/2015)... GenomeDx Biosciences announced that it will present at the Wedbush ... 12, in New York . Dave Matthews ... company,s Decipher ®  test and an overview of the Company,s ... Decipher ®  Prostate Cancer Classifier is a highly validated and ... risk prostate cancer. The test is the only genomic test ...
(Date:8/5/2015)... Gaithersburg, MD (PRWEB) , ... August 05, 2015 ... ... reagents for the life sciences, announces the launch of an updated corporate identity, ... acquired by Molecular Transfer, Inc. (MTI) in 2009. The company moved into a ...
(Date:8/4/2015)... 4, 2015 According to ... titled, "World Cardiac Biomarker - Market Opportunities, and ... generate the revenue of $2,085.9 million by 2020, ... 2020. Cardiac Troponins (T, I) would continue to ... to high sensitivity and specificity.      ...
Breaking Biology Technology:Biosimilars Forum Applauds Reps. Barton, Eshoo for Leadership on Proposed Medicare Rule on Biosimilar Coding 2Biosimilars Forum Applauds Reps. Barton, Eshoo for Leadership on Proposed Medicare Rule on Biosimilar Coding 3GenomeDx Biosciences to Present at 2015 Wedbush PacGrow Healthcare Conference 2GenomeDx Biosciences to Present at 2015 Wedbush PacGrow Healthcare Conference 3MTI-GlobalStem Announces Updated Company Identity and Website 2MTI-GlobalStem Announces Updated Company Identity and Website 3Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 3Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 4Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 5
... Revenue; Gross Margin Increase ... Continues; Net Losses Decline, IRVINE, ... device company focused on the development of,minimally invasive technologies for ... sales and procedures and,continued expense reductions in the three months ...
... SAN DIEGO, May 1 Vical Incorporated (Nasdaq:,VICL) today ... quarter ended March 31, 2008, before the opening of ... and webcast to discuss the,financial results and provide a ... The call is open on a listen-only basis to ...
... PRINCETON, N.J., May 1 Orchid Cellmark Inc.,(Nasdaq: ... testing,services, will release its first quarter 2008 financial results ... and is hosting a,conference call and webcast to discuss ... Management will discuss financial results for the first quarter,2008 ...
Cached Biology Technology:Endocare Reports 2008 First Quarter Financial Results 2Endocare Reports 2008 First Quarter Financial Results 3Endocare Reports 2008 First Quarter Financial Results 4Endocare Reports 2008 First Quarter Financial Results 5Endocare Reports 2008 First Quarter Financial Results 6Endocare Reports 2008 First Quarter Financial Results 7Endocare Reports 2008 First Quarter Financial Results 8Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results 2Orchid Cellmark to Announce First Quarter 2008 Financial Results on May 8, 2008 2
G-protein coupled purinergic receptor P2Y8...
Acid phosphatase (Potato). Monospecific by IEP. Some cross reactivity between Acid phosphatases of other species may occur....
Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
... to Yersinia pestis This antibody ... . Immunogen: Purified ... vaccine strain EV76. ... F1 capsular antigen. There is no ...
Biology Products: